|
Inappropriate sexual behaviour and dementia
When a patient with dementia displays inappropriate sexual behaviour in a residential setting such as a nursing home, this often causes disruption to the whole fabric of life in the home. Occasionally, old-age psychiatrists are
asked by general practitioners to provide assistance in managing such cases. In this article, Drs Richard Law-Min and Denise Cope explore the possible causes of, and discuss strategies to deal with, such disruptive behaviour.
Around 750000 people suffer from dementia in the UK, with AlzheimerÕs disease being the commonest cause (accounting for approximately 60per cent of cases)1. It is estimated that this figure will increase to 840000 by 20262. The prevalence of dementia is approximately 5per cent in those aged over 65years. Behavioural disturbances occur in about 60per cent of those with dementia3.
One study of a population of nursing home residents with dementia estimated the prevalence of inappropriate sexual behaviour (ISB) to be about 5per cent4. However, the true prevalence is difficult to measure as it depends on what is construed to be ISB. Depending on the tolerance level of staff, the problem might be under- or over-reported. It may also be reported under the rubric of behavioural features of dementia.
Defining inappropriate
sexual behaviour
ISB varies in severity and frequency but typically persists. It is directed mainly towards others but can be directed towards oneself. It can start suddenly or insidiously and is usually out of keeping with the patientÕs character. There is no evidence to suggest a link with a pre-morbid history of such behaviour or sexual offending6. ISB is more common in males than in females. The reason as to why this is so, however, is unclear.
Although ISB is uncommon, it can cause major distress and embarrassment to other residents and carers. It also poses many challenges to those professionals trying to curb the behaviour. Staff usually ask general practitioners to intervene when such behaviour becomes unmanageable. When general practitioners make a referral to the old-age psychiatric services, they generally have tried the person concerned on psychotropic medication but with minimal or no effect on the behaviour.
Causes
It has been suggested that disruption to the neural pathway related to sex drive or hormonal changes secondary to dementia may be responsible5. ISB has also been observed in conditions where the frontal lobe or temporal lobe (involved in regulating sexual drive) have been damaged, such as major head injury, PickÕs disease and Kluver-Bucy syndrome (characterized by placidity, hyperorality, and hypersexuality). It has also been reported in multiple sclerosis, subthalamic infarction, WilsonÕs disease and as a side-effect of antiparkinsonian drugs.
Psychological factors
Social factors
Assessment
Management
In practice, medication is probably used more readily than it should be. This may reflect a lack of resources in nursing homes (including staff shortages and a lack of skills) and the expectation upon general practitioners to prescribe medication and to do something quickly. Because many patients with dementia cannot consent to treatment, medications are given in their best interest. Although drugs are commonly used, most of them are not licensed for behavioural problems or ISB.
Non-pharmacological
interventions
This helps to relieve boredom and provides an alternative means of self-stimulation. Attempts should be made to separate the person from the target of their attentions. If the behaviour is an attempt to gain attention, then the subject may benefit from increased attention by nursing staff or spouse.
For someone who tends to masturbate or undress in front of others, modification of clothing, which makes undressing difficult, can work. Although a change of environment, by having the person moved to a different home, can resolve the problem, such a move can result in the problem simply being transferred from one home to another. Merely telling the person to stop the behaviour does not work as he or she often has poor understanding or forgets what has been said.
The above suggestions are not meant to be prescriptive as each case is different. What is important is to identify and address the actual triggers, and some degree of imagination may be required to fit the interventions to the patient.
When these interventions do not succeed, it is possible that the real triggers have not been identified and addressed. It is important that all staff adopt a consistent approach with the person, so that no mixed messages are given out and only the desired behaviours are rewarded. Staff may require education on the subject of ISB6.
Pharmacological interventions
In the case of trazodone, it is postulated that its successful use in patients with ISB may be related to the taming effect of the drug in animal models of aggression. Cimetidine has been shown to have antiandrogenic effects in rats by blocking testosterone synthesis. Just like SSRIs, the effects of buspirone and domipramine are related to increase in serotonin level. Success with anti-androgens such as medroxyprogesterone18 (300mg intramuscularly weekly) has also been reported.
Cyproterone acetate (100mg/day) has been tried in dementia but not in the elderly19. There are some reports on the use of oestrogens (e.g. diethylstilbestrol 1mg/day) in elderly demented men20. Use of GnRH analogues (such as leuprolide acetate) has been reported in young dementia only21.
In view of the limited evidence available, SSRIs are probably a good first option to try as they have the least problematic side-effect profile. It is suggested that SSRIs are effective because of their anti-obsessional effects and ISB may be a form of obsessive compulsive disorder22.
Reduced libido is also a common side-effect of SSRIs which may be useful in this situation. Tricyclics should be avoided as they can cause postural hypotension and increased confusion in the elderly. Anti-androgens and oestrogens may have a role to play as a last resort. However, their use is controversial and raises ethical and legal issues in this group of patients. They also potentially have more serious side-effects.
Although antipsychotic medications as chlorpromazine, risperidone, or olanzapine are probably commonly used, there is no good evidence of efficacy for their use in ISB.
Conclusion
References
2. Department of Health. National Service Framework for Older People. 2001; HMSO, London
3. Lyketsos CG, Steinberg M, Tschanz JT, et al. Mental and behavioural disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 2000; 157: 708Ð14
4. Wagner AW, Teri L, Orr-Rainey N. Behaviour problems of residents with dementia in special care units. AlzheimerÕs Disease and Associated Disorders 1995; 9(3): 121Ð7
5. Shapira J, Cummings JL. AlzheimerÕs disease: changes in sexual behaviour. Medical Aspects of Human Sexuality 1989; 6: 32Ð5
6. Kuhn RD, Greiner D, Arseneau L. Addressing hypersexuality in AlzheimerÕs disease. J Geontological Nursing 1998; 24(4): 44Ð50
7. Camp CJ, Cohen-Mansfield J, Capezuti EA. Use of nonpharmacologic interventions among nursing home residents with dementia. Psychiatric Services 2002; 53: 1397Ð1401
8. Burns A, Baldwin R. Prescribing psychotropic drugs for the elderly. Advances in Psychiatric Treatment 1994; 1: 24Ð31
9. Thapa PB, Gideon P, Fought RL, et al. Psychotropic drugs and the risk of recurrent falls in ambulatory nursing home residents. Am J Epidemiol 1995; 142: 202Ð11
10. Bartels SJ, Dums AR, Oxman TE, et al. Evidence-based practices in geriatric mental health care. Psychiatric Services 2002; 53(11): 1419Ð31
11. Robinson KM. Understanding hypersexuality, a behavioural disorder of dementia. Home Healthcare Nurse 2003; 21(1): 43Ð7
12. Levitsky AM, Owens NJ. Pharmacologic treatment of hypersexuality and paraphilias in nursing home residents. J Am Geriatr Soc 1999; 47: 231Ð4
13. Tiller JWG, Dakis JA, Shaw JM. Short-term buspirone treatment in disinhibition with dementia. Lancet 1988; 2(8609): 510
14. Simpson DM, Foster D. Improvement in organically disturbed behaviour with trazodone treatment. J Clin Psychiatry 1986; 47(4): 191Ð3
15. Stewart JT, Shin KJ. Paroxetine treatment of sexual disinhibition in dementia. Am J Psychiatry 1997; 154: 1474
16. Leo RJ, Kim KY. Clomipramine treatment of paraphilias in elderly demented patients. J Geriatr Psychiatry Neurol 1995; 8: 123Ð4
17. Wiseman SV, McAuley JW, Freidenberg GR, et al. Hypersexuality in patients with dementia: Possible response to cimetidine. Neurology 2000; 54: 2
18. Cooper AJ. Medroxyprogesterone acetate (MPA) treatment of sexual acting out in men suffering from dementia. J Clin psychiatry 1987; 48: 368Ð70
19. Nadal M, Allgulander S. Normalization of sexual berhaviour in a female with dementia after treatment with cyproterone. Int J Geriatr Psychiatry 1993; 8: 265Ð7
20. Lothstein LM, Fogg-Waberski J, Reynolds P. Risk management and treatment of sexual disinhibition in geriatric patients. Conn Med 1997; 61: 609Ð18
21. Ott BR. Leuprolide treatment of sexual aggression in a patient with dementia and the Kluver-Bucy syndrome. Clin Neuropharmacol 1995; 18: 443Ð7
22. Kafta MP. Sertraline pharmacology for paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiatry 1994; 6: 189Ð95
Dr Richard Law-Min is Specialist Registrar in Old Age Psychiatry, Alderney Hospital, Poole; Dr Denise Cope is Consultant in Old Age Psychiatry, Alderney
Community Hospital Ringwood Road, Parkstone, Poole, Dorset
|